We selected this definition of adequate response based on the FluLaval® Quadrivalent prescribing information that defines seroconversion as a 4-fold increase in post- vaccination antibody titer from pre-vaccination titer ≥1:10, or an increase in titer from <1:10 to ≥1:40.16 Although specific...
Fasenra [US prescribing information]. AstraZeneca pharmaceuticals LP; 2017. Google Scholar Dávila González I, Moreno Benítez F, Quirce S. Benralizumab: a new approach for the treatment of severe eosinophilic asthma. J Investig Allergol Clin Immunol. 2019;29(2):84–93. PubMed Google Schola...
We selected this definition of adequate response based on the FluLaval® Quadrivalent prescribing information that defines seroconversion as a 4-fold increase in post- vaccination antibody titer from pre-vaccination titer ≥1:10, or an increase in titer from <1:10 to ≥1:40.16 Although specific...